Your trusted destination for CME, CPD & Medical Education across the Middle East.
King Abdulaziz Medical City (KAMC), National Guard Health Affairs, Jeddah, Saudi Arabia
Dr. Alshehri is particularly relevant to your conference research because he was a consensus-panel participant in Management of Early and Metastatic Breast Cancer: A Consensus Statement from Oncologists in Saudi Arabia. The publication lists him with Meteb AlFoheidi under the Medical Oncology Department, King Saud University Medical City, Riyadh.
He is also a co-author of a 2026 GCC expert statement on second-line endocrine-based treatment for HR-positive/HER2-negative metastatic breast cancer, demonstrating his continuing involvement in regional breast-cancer treatment recommendations.
His professional credentials include ABIM (American Board of Internal Medicine), FRCPC (Royal College of Physicians and Surgeons of Canada), and MMedEd (Master of Medical Education). A specialist profile reports that he completed internal-medicine fellowship training at Dalhousie University in Canada, followed by fellowships in Medical Oncology, Breast Cancer and Gastrointestinal Cancer at the University of Alberta.
His publications cover several areas of oncology, including:
He was a co-author of research on treatment patterns and recommendations for hepatocellular carcinoma in Saudi Arabia, with his affiliation listed as the Department of Oncology, King Khalid National Guard Hospital, Abdulaziz Medical City, Jeddah.
He was also the corresponding author of a 2025 study mapping the colorectal cancer patient journey from the oncologist perspective in Saudi Arabia.
